Literature DB >> 16395268

Resistance to intercompartmental mass transfer limits beta2-microglobulin removal by post-dilution hemodiafiltration.

R A Ward1, T Greene, B Hartmann, W Samtleben.   

Abstract

Although clearance of beta(2)-microglobulin is greater with hemodiafiltration than with high-flux hemodialysis, beta(2)-microglobulin concentrations after long-term hemodiafiltration are only slightly less than those obtained with high-flux hemodialysis. Resistance to beta(2)-microglobulin transfer between body compartments could explain this observation. beta(2)-Microglobulin kinetics were determined in patients receiving on-line post-dilution hemodiafiltration for 4 h with 18 l of filtration. Plasma beta(2)-microglobulin concentrations were measured during and for 2 h following hemodiafiltration and immediately before the next treatment. The filter clearance of beta(2)-microglobulin was determined from arterial and venous concentrations. The beta(2)-microglobulin generation rate was calculated from the change in the plasma concentration between treatments. The intercompartmental clearance was obtained by fitting the observed concentrations to a two-compartment, variable volume model. The plasma clearance of beta(2)-microglobulin by the filter was 73 +/- 2 ml/min. Plasma beta(2)-microglobulin concentrations decreased by 68 +/- 2% from pre- to post-treatment (27.1 +/- 2.2-8.5 +/- 0.7 mg/l), but rebounded by 32+/-3% over the next 90 min. The generation rate of beta(2)-microglobulin was 0.136 +/- 0.008 mg/min. The model fit yielded an intercompartmental clearance of 82 +/- 7 ml/min and a volume of distribution of 10.2 +/- 0.6 l, corresponding to 14.3 +/- 0.7% of body weight. Hemodiafiltration provides a beta(2)-microglobulin clearance of similar magnitude to the intercompartmental clearance within the body. As a result, intercompartmental mass transfer limits beta(2)-microglobulin removal by hemodiafiltration. This finding suggests that alternative strategies, such as increased treatment times or frequency of treatment, are needed to further reduce plasma beta(2)-microglobulin concentrations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395268     DOI: 10.1038/sj.ki.5000048

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  35 in total

Review 1.  Searching for uremic toxins.

Authors:  Mirela Dobre; Timothy W Meyer; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

Review 2.  Novel approaches for reducing free light chains in patients with myeloma kidney.

Authors:  Colin A Hutchison; Joan Bladé; Paul Cockwell; Mark Cook; Mark Drayson; Jean-Paul Fermand; Efstathios Kastritis; Robert Kyle; Nelson Leung; Sonia Pasquali; Christopher Winearls
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

3.  Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis.

Authors:  Baris U Agar; Alp Akonur; Ying-Cheng Lo; Alfred K Cheung; John K Leypoldt
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

4.  Dialysis cannot be dosed.

Authors:  Timothy W Meyer; Tammy L Sirich; Thomas H Hostetter
Journal:  Semin Dial       Date:  2011-09-19       Impact factor: 3.455

5.  Residual Function Effectively Controls Plasma Concentrations of Secreted Solutes in Patients on Twice Weekly Hemodialysis.

Authors:  Sheldon C Leong; Justin N Sao; Abigail Taussig; Natalie S Plummer; Timothy W Meyer; Tammy L Sirich
Journal:  J Am Soc Nephrol       Date:  2018-05-04       Impact factor: 10.121

Review 6.  Approaches to uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

7.  Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients.

Authors:  E Lars Penne; Neelke C van der Weerd; Peter J Blankestijn; Marinus A van den Dorpel; Muriel P C Grooteman; Menso J Nubé; Piet M Ter Wee; Renée Lévesque; Michiel L Bots
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-12       Impact factor: 8.237

8.  Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules.

Authors:  Joon-Sung Park; Gheun-Ho Kim; Chong Myung Kang; Chang Hwa Lee
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 3.165

9.  Classification of Uremic Toxins and Their Role in Kidney Failure.

Authors:  Mitchell H Rosner; Thiago Reis; Faeq Husain-Syed; Raymond Vanholder; Colin Hutchison; Peter Stenvinkel; Peter J Blankestijn; Mario Cozzolino; Laurent Juillard; Kianoush Kashani; Manish Kaushik; Hideki Kawanishi; Ziad Massy; Tammy Lisa Sirich; Li Zuo; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2021-07-07       Impact factor: 8.237

10.  Precision medicine in transplantation and hemodialysis.

Authors:  Rainer Oberbauer; Timothy W Meyer
Journal:  Nephrol Dial Transplant       Date:  2021-06-22       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.